II. Statement of the Problem * How would Generoso Pharmaceuticals & Chemicals, Inc. adapt with the changes to stay in the pharmaceutical industry?
* How would Generoso Pharmaceuticals & Chemicals, Inc. pursue its planned development?
III. Statement of the Objectives * To sustain the business or continue in the industry * To pursue planned development * To adapt to the changes in the company’s environment
IV. Areas of Consideration * Competitors and Potential Entrants in the industry * Economic Trends * Administrative and Political Factors (Laws, Rules, Regulations) – The Generics Act of 1988 * Geographic and Demographic features of the market * Cost for development (Materials, Labor, Equipment, etc.) * SWOT ANALYSIS * Strengths * Company’s philosophy and values * Good track record of the company in terms of quality, price, presentation, etc. * Broad experience of the owners in the pharmaceutical industry * Status orientation of the owners * Wide range of registered products in BFAD * Being small has an advantage of having small overhead cost
* Weaknesses * Insufficient human resource * Risk orientation (low) * Multinational firms have bigger range of market compared to smaller companies like GPC
* Opportunities * Venturing to other business * Expansion and variation of products * Accepting project proposals * Trade marking * Small firms like GPC can adapt more to the Generics Act of 1988
* Threats * Differences between David’s and Rafael’s leadership strategy * Fast turnover of participants in the industry * Unavailability of required resource to venture with the proposed project * High cost of drugs
